{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:01:03Z","timestamp":1787068863464,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cultured brain slices rapidly replicate murine prions, exhibit prion pathology, and are amenable towards drug discovery, but have not been infected with human prions. As deer mice (\n                    <jats:italic>Peromyscus maniculatus<\/jats:italic>\n                    ) are susceptible to human prions in vivo, here we investigated deer mouse organotypic brain slice cultures as a potential model of human prion disease. Deer mouse brain slices supported replication of rodent-adapted strains of scrapie and Creutzfeldt-Jakob disease (CJD), but they resisted infection with primary human prion inoculum. To better understand this discrepancy, we quantified prion replication rates, characterized cellular and molecular changes, and estimated inoculum clearance within wildtype CD1 and deer mouse brain slice cultures. Prion replication rates varied by species, strain, and brain region, independently of PrP sequence homology. Scrapie-infected CD1 cerebellar slice cultures exhibited the fastest prion replication rate, closely matching in vivo bioassay kinetics and showing neuronal and synaptic degeneration at similar timepoints. However, deer mouse slice cultures replicated deer mouse-adapted sCJD MM1 prions less efficiently than in vivo inoculation. These findings clarify both the utility and constraints of brain slice cultures in modeling prion disease and imply that the slice culture molecular environment may be suboptimal for human prion replication.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-01999-w","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:13:56Z","timestamp":1745972036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prion replication in organotypic brain slice cultures is distinct from in vivo inoculation and is species dependent"],"prefix":"10.1186","volume":"13","author":[{"given":"Jessy A.","family":"Slota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Myskiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy L.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M. S.","family":"Kielich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Thapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben A.","family":"Bailey-Elkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"1999_CR1","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363\u201313383","journal-title":"Proc Natl Acad Sci USA"},{"key":"1999_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jnnp.2004.048660","volume":"76","author":"J Collinge","year":"2005","unstructured":"Collinge J (2005) Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76:906\u2013919","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1999_CR3","first-page":"1612","volume":"21","author":"MD Geschwind","year":"2018","unstructured":"Geschwind MD (2018) Prion Diseases. Continuum (Minneapolis, Minn) 21:1612\u20131638","journal-title":"Continuum (Minneapolis, Minn)"},{"key":"1999_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-444-63945-5.00010-6","volume":"153","author":"S Notari","year":"2018","unstructured":"Notari S, Appleby BS, Gambetti P (2018) Variably protease-sensitive prionopathy. Handb Clin Neurol 153:175\u2013190","journal-title":"Handb Clin Neurol"},{"key":"1999_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.pmbts.2017.06.014","volume":"150","author":"A Mar\u00edn-Moreno","year":"2017","unstructured":"Mar\u00edn-Moreno A, Fern\u00e1ndez-Borges N, Espinosa JC, Andr\u00e9oletti O, Torres JM (2017) Transmission and replication of prions. Prog Mol Biol Transl Sci 150:181\u2013201","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1999_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molmed.2010.09.001","volume":"17","author":"C Soto","year":"2011","unstructured":"Soto C, Satani N (2011) The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 17:14\u201314","journal-title":"Trends Mol Med"},{"key":"1999_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nmeth0308-211","volume":"5","author":"R Atarashi","year":"2008","unstructured":"Atarashi R et al (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5:211\u2013212","journal-title":"Nat Methods"},{"key":"1999_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810\u2013813","journal-title":"Nature"},{"key":"1999_CR9","doi-asserted-by":"publisher","first-page":"19841","DOI":"10.1074\/jbc.R114.550707","volume":"289","author":"JC Watts","year":"2014","unstructured":"Watts JC, Prusiner SB (2014) Mouse models for studying the formation and propagation of prions. J Biol Chem 289:19841\u201319841","journal-title":"J Biol Chem"},{"key":"1999_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.pmbts.2020.08.007","volume":"175","author":"A Mar\u00edn-Moreno","year":"2020","unstructured":"Mar\u00edn-Moreno A, Espinosa JC, Torres JM (2020) Transgenic mouse models for the study of prion diseases. Prog Mol Biol Transl Sci 175:147\u2013177","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1999_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/bs.pmbts.2020.08.009","volume":"175","author":"H Arshad","year":"2020","unstructured":"Arshad H, Bourkas MEC, Watts JC (2020) The utility of bank voles for studying prion disease. Prog Mol Biol Transl Sci 175:179\u2013211","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1999_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1128\/JVI.00560-09","volume":"84","author":"DM Heisey","year":"2010","unstructured":"Heisey DM et al (2010) Chronic wasting disease (CWD) susceptibility of several north American rodents that are sympatric with cervid CWD epidemics. J Virol 84:210\u2013210","journal-title":"J Virol"},{"key":"1999_CR13","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1074\/jbc.M512239200","volume":"281","author":"N Piening","year":"2006","unstructured":"Piening N et al (2006) Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo. J Biol Chem 281:9373\u20139384","journal-title":"J Biol Chem"},{"key":"1999_CR14","doi-asserted-by":"publisher","first-page":"e1000113","DOI":"10.1371\/journal.ppat.1000113","volume":"4","author":"U Agrimi","year":"2008","unstructured":"Agrimi U et al (2008) Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles. PLoS Pathog 4:e1000113","journal-title":"PLoS Pathog"},{"key":"1999_CR15","doi-asserted-by":"publisher","first-page":"e1012538","DOI":"10.1371\/journal.ppat.1012538","volume":"20","author":"H Arshad","year":"2024","unstructured":"Arshad H et al (2024) The molecular determinants of a universal prion acceptor. PLoS Pathog 20:e1012538","journal-title":"PLoS Pathog"},{"key":"1999_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/v5010374","volume":"5","author":"A Grassmann","year":"2013","unstructured":"Grassmann A, Wolf H, Hofmann J, Graham J, Vorberg I (2013) Cellular aspects of prion replication in vitro. Viruses 5:374\u2013374","journal-title":"Viruses"},{"key":"1999_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4939-7244-9_7","volume":"1658","author":"SA Priola","year":"2017","unstructured":"Priola SA (2017) Cell biology approaches to studying prion diseases. Methods Mol Biol (Clifton, N.J.) 1658:83\u201394","journal-title":"Methods Mol Biol (Clifton, N.J.)"},{"key":"1999_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.coph.2019.02.002","volume":"44","author":"I Vorberg","year":"2019","unstructured":"Vorberg I, Chiesa R (2019) Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds. Curr Opin Pharmacol 44:28\u201338","journal-title":"Curr Opin Pharmacol"},{"key":"1999_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/S00441-022-03630-Z","author":"H Arshad","year":"2022","unstructured":"Arshad H, Watts JC (2022) Genetically engineered cellular models of prion propagation. Cell Tissue Res. https:\/\/doi.org\/10.1007\/S00441-022-03630-Z","journal-title":"Cell Tissue Res"},{"key":"1999_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007283","volume":"14","author":"C Fang","year":"2018","unstructured":"Fang C et al (2018) Prions activate a p38 MAPK synaptotoxic signaling pathway. PLoS Pathog 14:e1007283","journal-title":"PLoS Pathog"},{"key":"1999_CR21","doi-asserted-by":"publisher","first-page":"e1007712","DOI":"10.1371\/journal.ppat.1007712","volume":"15","author":"ST Foliaki","year":"2019","unstructured":"Foliaki ST et al (2019) Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc. PLoS Pathog 15:e1007712","journal-title":"PLoS Pathog"},{"key":"1999_CR22","doi-asserted-by":"publisher","first-page":"12271","DOI":"10.1073\/pnas.0402725101","volume":"101","author":"S Cronier","year":"2004","unstructured":"Cronier S, Laude H, Peyrin JM (2004) Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci USA 101:12271\u201312276","journal-title":"Proc Natl Acad Sci USA"},{"key":"1999_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-13455-z","volume":"12","author":"M Reilly","year":"2022","unstructured":"Reilly M et al (2022) A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody. Sci Rep 12:1","journal-title":"Sci Rep"},{"key":"1999_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-019-0742-2","volume":"7","author":"BR Groveman","year":"2019","unstructured":"Groveman BR et al (2019) Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun 7:12","journal-title":"Acta Neuropathol Commun"},{"key":"1999_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13287-023-03591-2","volume":"14","author":"K Williams","year":"2023","unstructured":"Williams K et al (2023) Neural cell engraftment therapy for sporadic Creutzfeldt-Jakob disease restores neuroelectrophysiological parameters in a cerebral organoid model. Stem Cell Res Ther 14:348","journal-title":"Stem Cell Res Ther"},{"key":"1999_CR26","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1038\/s41598-021-84689-6","volume":"11","author":"BR Groveman","year":"2021","unstructured":"Groveman BR et al (2021) Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease. Sci Rep 11:5165","journal-title":"Sci Rep"},{"key":"1999_CR27","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0140-6736(95)90508-1","volume":"345","author":"A Ladogana","year":"1995","unstructured":"Ladogana A, Liu Q, Geng Xi Y, Pocchiari M (1995) Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeldt-Jakob patient. Lancet (London, England) 345:594\u2013595","journal-title":"Lancet (London, England)"},{"key":"1999_CR28","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1084\/jem.20161547","volume":"214","author":"Z Krejciova","year":"2017","unstructured":"Krejciova Z et al (2017) Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner. J Exp Med 214:3481\u20133495","journal-title":"J Exp Med"},{"key":"1999_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/infdis\/jit623","volume":"209","author":"S Hannaoui","year":"2014","unstructured":"Hannaoui S et al (2014) Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific. J Infect Dis 209:1144\u20131148","journal-title":"J Infect Dis"},{"key":"1999_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/pathogens10081060","volume":"10","author":"JH W\u00e4lzlein","year":"2021","unstructured":"W\u00e4lzlein JH, Schwenke KA, Beekes M (2021) Propagation of CJD prions in primary murine glia cells expressing human PrPc. Pathogens 10:1060","journal-title":"Pathogens"},{"key":"1999_CR31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/biom10071079","volume":"10","author":"H Pineau","year":"2020","unstructured":"Pineau H, Sim V (2020) POSCAbilities: the application of the prion organotypic slice culture assay to neurodegenerative disease research. Biomolecules 10:1079","journal-title":"Biomolecules"},{"key":"1999_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nn2028","volume":"11","author":"J Falsig","year":"2008","unstructured":"Falsig J et al (2008) A versatile prion replication assay in organotypic brain slices. Nat Neurosci 11:109\u2013117","journal-title":"Nat Neurosci"},{"key":"1999_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nprot.2008.13","volume":"3","author":"J Falsig","year":"2008","unstructured":"Falsig J, Aguzzi A (2008) The prion organotypic slice culture assay\u2013POSCA. Nat Protoc 3:555\u2013562","journal-title":"Nat Protoc"},{"key":"1999_CR34","doi-asserted-by":"publisher","first-page":"e1002985","DOI":"10.1371\/journal.ppat.1002985","volume":"8","author":"J Falsig","year":"2012","unstructured":"Falsig J et al (2012) Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLoS Pathog 8:e1002985","journal-title":"PLoS Pathog"},{"key":"1999_CR35","doi-asserted-by":"publisher","first-page":"43155","DOI":"10.1038\/srep43155","volume":"7","author":"N Kondru","year":"2017","unstructured":"Kondru N et al (2017) Integrated organotypic slice cultures and RT-QuIC (OSCAR) assay: implications for translational discovery in protein misfolding diseases. Sci Rep 7:43155","journal-title":"Sci Rep"},{"key":"1999_CR36","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1038\/s41598-020-64456-9","volume":"10","author":"N Kondru","year":"2020","unstructured":"Kondru N et al (2020) An ex vivo brain slice culture model of chronic wasting disease: implications for disease pathogenesis and therapeutic development. Sci Rep 10:7640","journal-title":"Sci Rep"},{"key":"1999_CR37","doi-asserted-by":"publisher","first-page":"e81776","DOI":"10.1371\/journal.pone.0081776","volume":"8","author":"JL Campeau","year":"2013","unstructured":"Campeau JL, Wu G, Bell JR, Rasmussen J, Sim VL (2013) Early increase and late decrease of purkinje cell dendritic spine density in prion-infected organotypic mouse cerebellar cultures. PLoS ONE 8:e81776","journal-title":"PLoS ONE"},{"key":"1999_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature09768","volume":"470","author":"MK Sandberg","year":"2011","unstructured":"Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470:540\u2013542","journal-title":"Nature"},{"key":"1999_CR39","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1038\/ncomms5347","volume":"5","author":"MK Sandberg","year":"2014","unstructured":"Sandberg MK et al (2014) Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked. Nat Commun 5:4347","journal-title":"Nat Commun"},{"key":"1999_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41594-021-00565-x","volume":"28","author":"G Meisl","year":"2021","unstructured":"Meisl G et al (2021) Scaling analysis reveals the mechanism and rates of prion replication in vivo. Nat Struct Mol Biol 28:365\u2013372","journal-title":"Nat Struct Mol Biol"},{"key":"1999_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03572-w","volume":"5","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions. Commun Biol 5:1\u201311","journal-title":"Commun Biol"},{"key":"1999_CR42","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.15252\/embj.201387150","volume":"33","author":"MM Marbiah","year":"2014","unstructured":"Marbiah MM et al (2014) Identification of a gene regulatory network associated with prion replication. EMBO J 33:1527\u20131547","journal-title":"EMBO J"},{"key":"1999_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0301-4622(99)00016-2","volume":"77","author":"J Masel","year":"1999","unstructured":"Masel J, Jansen VAA, Nowak MA (1999) Quantifying the kinetic parameters of prion replication. Biophys Chem 77:139\u2013152","journal-title":"Biophys Chem"},{"key":"1999_CR44","doi-asserted-by":"publisher","first-page":"17971","DOI":"10.1073\/pnas.0708372104","volume":"104","author":"S Ghaemmaghami","year":"2007","unstructured":"Ghaemmaghami S et al (2007) Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci USA 104:17971\u201317976","journal-title":"Proc Natl Acad Sci USA"},{"key":"1999_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/19336896.2023.2206315","volume":"17","author":"JA Slota","year":"2023","unstructured":"Slota JA, Wang X, Lusansky D, Medina SJ, Booth SA (2023) Differentiated cultures of an immortalized human neural progenitor cell line do not replicate prions despite PrPC overexpression. Prion 17:116\u2013132","journal-title":"Prion"},{"key":"1999_CR46","doi-asserted-by":"crossref","unstructured":"Martin D et al (2021) Prion potentiation after life-long dormancy in mice devoid of PrP. Brain Commun 3","DOI":"10.1093\/braincomms\/fcab092"},{"key":"1999_CR47","doi-asserted-by":"publisher","first-page":"e1008495","DOI":"10.1371\/journal.ppat.1008495","volume":"16","author":"CM Burke","year":"2020","unstructured":"Burke CM et al (2020) Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation. PLoS Pathog 16:e1008495","journal-title":"PLoS Pathog"},{"key":"1999_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00401-017-1782-y","volume":"135","author":"N Fern\u00e1ndez-Borges","year":"2018","unstructured":"Fern\u00e1ndez-Borges N et al (2018) Cofactors influence the biological properties of infectious recombinant prions. Acta Neuropathol 135:179\u2013199","journal-title":"Acta Neuropathol"},{"key":"1999_CR49","doi-asserted-by":"publisher","first-page":"e1007093","DOI":"10.1371\/journal.ppat.1007093","volume":"14","author":"E Katorcha","year":"2018","unstructured":"Katorcha E, Gonzalez-Montalban N, Makarava N, Kovacs GG, Baskakov IV (2018) Prion replication environment defines the fate of prion strain adaptation. PLoS Pathog 14:e1007093","journal-title":"PLoS Pathog"},{"key":"1999_CR50","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/s41467-018-04584-z","volume":"9","author":"C Kim","year":"2018","unstructured":"Kim C et al (2018) Artificial strain of human prions created in vitro. Nat Commun 9:2166","journal-title":"Nat Commun"},{"key":"1999_CR51","doi-asserted-by":"publisher","first-page":"E1938","DOI":"10.1073\/pnas.1206999109","volume":"109","author":"NR Deleault","year":"2012","unstructured":"Deleault NR et al (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci USA 109:E1938-1946","journal-title":"Proc Natl Acad Sci USA"},{"key":"1999_CR52","doi-asserted-by":"crossref","unstructured":"Lamoureux L et al (2022) Non-productive infection of glial cells with SARS-CoV-2 in Hamster organotypic cerebellar slice cultures. Viruses 14","DOI":"10.3390\/v14061218"},{"key":"1999_CR53","doi-asserted-by":"publisher","unstructured":"Opitz-Araya X, Barria A (2011) Organotypic hippocampal slice cultures. J Vis Exp 2462. https:\/\/doi.org\/10.3791\/2462","DOI":"10.3791\/2462"},{"key":"1999_CR54","doi-asserted-by":"crossref","unstructured":"Slota, J. A., Medina, S. J., Frost, K. L. & Booth, S. A. Neurons and Astrocytes Elicit Brain Region Specific Transcriptional Responses to Prion Disease in the Murine CA1 and Thalamus. Frontiers in neuroscience 16, (2022).","DOI":"10.3389\/fnins.2022.918811"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01999-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-01999-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01999-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:04:12Z","timestamp":1745975052000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-01999-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-01999-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments involving live animals were approved under animal use document (AUD) H15-032 or AUD H20-001 by the Animal Care Committee (ACC) of the Canadian Science Centre for Human and Animal Health (CSHAH). Human tissues were approved for use in research with appropriate consent under Health Canada-Public Health Agency of Canada (HC-PHAC) Research Ethics Board (REB) reference number REB 2017-009P.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}